Condition (MeSH)
Agoraphobia
ClinicalTrials.gov lists 60 trials for Agoraphobia or a narrower condition beneath it. Sorlandet Hospital HF has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
60 of the 60 trials are tagged with Agoraphobia itself; the rest are tagged with a narrower condition beneath it.
When did Agoraphobia trials start? (26)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 7
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 7 |
| 2024 | 3 |
| 2023 | 1 |
| 2022 | 3 |
| 2021 | 3 |
| 2020 | 2 |
| 2019 | 5 |
| 2018 | 6 |
| 2017 | 4 |
Showing 10 of 26 earlier years.
No forecast is made for this condition: it averages 3.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 36 months from start to primary completion across 12 trials still running at the 2026-10-09 snapshot; registered median of 37 months across 38 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Agoraphobia trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Phase 2 | 2 |
| Phase 2/3 | 1 |
| Phase 3 | 4 |
| Phase 4 | 4 |
| Not applicable | 45 |
| Observational | 3 |
How many Agoraphobia trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 8 |
| Active, not recruiting | 2 |
| Completed | 34 |
| Terminated | 2 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Agoraphobia trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Sorlandet Hospital HF | 2 |
Which drugs are being tested for Agoraphobia? (5)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Cannabidiol | 1 |
| METHYLPHENIDATE | 1 |
| Clonazepam | 1 |
| D-Cycloserine | 1 |
| CBT | 1 |
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Treatment As Usual | 2 |
| Paroxetine IR | 1 |
| TAU | 1 |
| Sertralin | 1 |
| Sunflower Lecithin Oil in Capsule | 1 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Agoraphobia trials report? (3)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| hospitalization | 2 | 1 |
| psychiatric hospitalization | 2 | 1 |
| EMS call - Emergency Visit | 1 | 1 |
Which publications cover Agoraphobia? (97)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| The Oxford Agoraphobic Avoidance Scale. | Psychological medicine | 2023 | Yes |
| Social anxiety and agoraphobia symptoms effectively treated by Prompt Mental Health Care versus TAU at 6- and 12-month follow-up: Secondary analysis from a randomized controlled trial. | Depression and anxiety | 2021 | Yes |
| Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes. | Translational psychiatry | 2019 | Yes |
| Association of NPSR1 gene variation and neural activity in patients with panic disorder and agoraphobia and healthy controls. | NeuroImage. Clinical | 2019 | Yes |
| Anxiety disorders and CRP in a population cohort study with 54,326 participants: The LifeLines study. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry | 2018 | Yes |
Showing 5 of 97 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.